[1]丁永福.健脾清肠汤治疗脾虚湿热型溃疡性结肠炎40例[J].西部中医药,2018,31(02):88-90.
　DING Yongfu.JianPi QingChang Decoction in Treating 40 Cases of Ulcerative Colitis of Spleen-deficiency Damp-heat Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(02):88-90.
点击复制

健脾清肠汤治疗脾虚湿热型溃疡性结肠炎40例()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年02期
页码:
88-90
栏目:
出版日期:
2018-02-15

文章信息/Info

Title:
JianPi QingChang Decoction in Treating 40 Cases of Ulcerative Colitis of Spleen-deficiency Damp-heat Pattern
文章编号:
1004-6852(2018)02-0088-03
作者:
丁永福
临泽县中医医院，甘肃 临泽 734200
Author(s):
DING Yongfu
Linze County TCM Hospital, Linze 734200, China
关键词:
结肠炎; 溃疡性; 脾虚湿热型; 健脾清肠汤
Keywords:
colitis;  ulcerative;  spleen-deficiency damp-heat pattern;  JianPi QingChang decoction
分类号:
R516.1
文献标志码:
B
摘要:
目的：观察健脾清肠汤治疗脾虚湿热型溃疡性结肠炎的临床疗效。方法：将80例患者随机分为观察组、对照组各40例，对照组行对症支持处理，观察组在对照组治疗的基础上服用健脾清肠汤，每日1剂。2组均连续治疗1个月。观察2组临床症状改善时间、炎症相关因子水平及Truelove分级情况。结果：腹痛腹胀、腹泻、便血及里急后重改善时间观察组均早于对照组，差异有统计学意义(P＜0.05)。肿瘤坏死因子α(TNF-α)、白介素6(IL-6)、超敏C反应蛋白(hs-CRP)水平干预后观察组均低于对照组，差异有统计学意义(P＜0.05)。肠镜复查Truelove分级中Ⅱ级及以下者干预后观察组37例(92.5%)，对照组29例(72.5%)，2组比较差异有统计学意义(P＜0.05)。结论：健脾清肠汤治疗慢性溃疡性结肠炎，能较快的缓解患者临床症状，减轻机体炎症反应，提高临床治疗效果。
Abstract:
Objective: To observe therapeutic effects of JianPi QingChang decoction in treating ulcerative colitis (UC). Methods: Eighty patients were randomized into the observation group and the control group, 40 cases each group, the control group accepted symptomatic treatment, and the observation group took JianPi QingChang decoction on the foundation of the treatment the control group received, one dose each day. Both groups were treated for one month consecutively. Truelove classification conditions, the levels of inflammatory factors and the improving time of clinical symptoms of both groups were observed. Results: The observation group was earlier than the control group in the improving time of abdominal pain, abdominal distension, diarrhea, hematochezia and tenesmus, and the difference showed statistical meaning (P＜0.05). The observation group was lower than the control group in the levels of TNF-α, IL-6 and hs-CRP, and the difference was statistically significant (P＜0.05). There were 37 cases (92.5%) in the observation group and 29 cases (72.5%) in the control group of grade Ⅱ amd lower than grade Ⅱ after the intervention according to Truelove classification, and the difference showed statistical meaning (P＜0.05). Conclusion: JianPi QingChang decoction in treating UC patients could relieve clinical symptoms rapidly, alleviate inflammatory reaction of the body and improve clinical therapeutic effects.

相似文献/References:

[1]黄文静.猴耳环消炎颗粒治疗婴幼儿过敏性结肠炎40例[J].西部中医药,2019,32(06):80.
　HUANG Wenjing.Treating 40 Cases of Infantile Allergic Colitis with HouErHuan XiaoYan Granules[J].Western Journal of Traditional Chinese Medicine,2019,32(02):80.
[2]常文丽,李晓华,邵秋香,等.中药口服液联合中药直肠滴入对溃疡性直肠炎临床疗效和炎症因子及凝血指标的影响[J].西部中医药,2023,36(08):119.[doi:10.12174/j.issn.2096-9600.2023.08.29]
　CHANG Wenli,LI Xiaohua,SHAO Qiuxiang,et al.Clinical Effects of Oral Liquid of Chinese Medicine and Rectal Dripping of Chinese Medicine in the Treatment of Ulcerative Rectitis and Its Impacts on Inflammatory Factors and Coagulation Indicators[J].Western Journal of Traditional Chinese Medicine,2023,36(02):119.[doi:10.12174/j.issn.2096-9600.2023.08.29]
[3]武颜荣,阚存玲.固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎19例*[J].西部中医药,2013,26(01):79.
　WU Yanrong,KAN Cunling.Clinical Observation on GuBen Y iChang Tablets and Mesalazine Tablets in Treating Moderate and Severe Ulcerative Colitis：A Report of 19 Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(02):79.
[4]冉玉.消溃愈疡汤联合艾迪莎治疗溃疡性结肠炎50例[J].西部中医药,2013,26(03):101.
　RAN Yu.XiaoKui YuYangTang and Etiasa in Treating 50 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(02):101.
[5]景姗,王新月,杨雪,等.溃疡性结肠炎大鼠肺、肠组织中TGF-β1、SP-A表达的改变及中药的干预作用*[J].西部中医药,2014,27(03):10.
　JING Shan,WANG Xinyue,YANG Xue,et al.The Expressions of TGF-β1 and SP-A in the Lung and the Intestines of Rats with Ulcerative Colitis and TCM Intervention on the Changes[J].Western Journal of Traditional Chinese Medicine,2014,27(02):10.
[6]张艳.初发与复发溃疡性结肠炎院外治疗依从性的调查与分析[J].西部中医药,2017,30(02):58.
　ZHANG Yan.Investigation and Analysis of Extramural Hospital Treatment Compliance of Incipient and Relapse Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2017,30(02):58.
[7]何永成,马国杰.中医分期治疗溃疡性结肠炎43例[J].西部中医药,2018,31(08):81.
　HE Yongcheng,MA Guojie.TCM Phased Therapy in Treating 43 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(02):81.
[8]杨薇薇.SASP加中药保留灌肠治疗溃疡性结肠炎64例[J].西部中医药,2019,32(01):102.
　YANG Weiwei.Treating 64 Cases of Ulcerative Colitis by SASP and Herbal Retention Enema[J].Western Journal of Traditional Chinese Medicine,2019,32(02):102.
[9]陈步强,常忠生,指导：陆金根.陆金根教授治疗轻中度溃疡性结肠炎学术思想探析[J].西部中医药,2020,33(02):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
　CHEN Buqiang,CHANG ZhongshengDirector: LU Jingen.Professor Lu Jingen′s Academic Thinking of Treating Mild - to - moderate Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2020,33(02):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
[10]沈照峰,朱磊,刘亚军,等.基于德尔菲法的溃疡性结肠炎患者相关危险因素调查分析[J].西部中医药,2020,33(04):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
　SHEN Zhaofeng,ZHU Lei,LIU Yajun,et al.An Investigation into the Related Risk Factors of UC Patients Based on Delphi Method[J].Western Journal of Traditional Chinese Medicine,2020,33(02):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
[11]杨洁,施丽婕.化瘀通阳方对溃疡性结肠炎大鼠IL-23/JAK-STAT信号通路的影响[J].西部中医药,2021,34(04):17.[doi:10.12174/j.issn.2096-9600.2021.04.05]
　YANG Jie,SHI Lijie.Effects of Stasis-resolving Yang-activating Prescription on IL-23/JAK-STAT Signaling Pathway in UC Rats[J].Western Journal of Traditional Chinese Medicine,2021,34(02):17.[doi:10.12174/j.issn.2096-9600.2021.04.05]
[12]杨武,张涛,廖美华,等.基于古代文献挖掘探析从肺肾论治溃疡性结肠炎[J].西部中医药,2023,36(10):67.[doi:10.12174/j.issn.2096-9600.2023.10.15]
　YANG Wu,ZHANG Tao,LIAO Meihua,et al.Treatment of Ulcerative Colitis from Lung and Kidney Based on Ancient Literature Mining[J].Western Journal of Traditional Chinese Medicine,2023,36(02):67.[doi:10.12174/j.issn.2096-9600.2023.10.15]

备注/Memo

备注/Memo:
收稿日期：2017-02-03 作者简介：丁永福(1974—)，男，副主任药师。研究方向：临床药学。
更新日期/Last Update: 2018-02-15